MET immunolabelling is a useful predictive tool for MET gene amplification in glioblastoma

Burel-Vandenbos, F; Ngo-Mai, M; Dadone, B; Di Mauro, I; Gimet, S; Saada-Bouzid, E; Bourg, V; Almairac, F; Fontaine, D; Virolle, T; Pedeutour, F

Burel-Vandenbos, F (reprint author), Hop Louis Pasteur, Lab Cent Anat Pathol, 30 Voie Romaine, F-06001 Nice 1, France.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2017; 43 (3): 252

Abstract

AimsMET gene amplification is rare in glioblastoma (GBM) and represents a potential target for MET inhibitors. An immunohistochemical screening may be......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索